March 19, 2018March 19, 2018

TNF Inhibitors Do Not Increase Risk of Tumor Malignancy in Pediatric IBD, Study Shows

News

Treatment of pediatric inflammatory bowel disease (pIBD) with tumor necrosis factor inhibitors (TNFi) does not increase the risk for malignancy, researchers report. The study with that finding, “Risk of malignancy associated ... Read more

March 7, 2016March 7, 2016

IBD Patients with Prior Cancer May Run ‘Mild Risk’ of Recurrence with Use of Anti-TNF Therapy

IBD News, News

Research into the risk of new cancers in inflammatory bowel disease (IBD) patients treated for a prior malignancy and undergoing anti-tumor necrosis factor (anti-TNF) therapy supported the treatment’s use, but found a slight risk ... Read more